Yeast-Based Virus-like Particles as an Emerging Platform for Vaccine Development and Delivery
Article in Vaccines (February 2023)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Advantages of yeast-based recombinant protein technology as vaccine products against infectious diseases
Article in IOP Conference Series Earth and Environmental Science (November 2021)
Yeast-based vaccines: New perspective in vaccine development and application
Article in FEMS Yeast Research (January 2019)